Kimball Electronics Expands Medical Footprint with European CDMO Acquisition
KE sits 41% above its 52-week low of $18.04.
Summary
Kimball Electronics has acquired Helvoet Polymer Technologies B.V., a European-based medical Contract Development and Manufacturing Organization (CDMO). This strategic acquisition expands Kimball's capabilities and market presence within the medical sector, particularly in Europe. The move follows the company's strong Q3 results and affirmed full-year guidance reported in May, signaling continued growth initiatives.
At the time of this announcement, KE was trading at $25.49 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $615.7M. The 52-week trading range was $18.04 to $33.19. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.